| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |